API標準品(対照薬)
各種APIの同定・定量時の標準物質を取り揃えております。
当品目は、弊社にて日本向けの代理店を行っいる Clearsynth Lab より供給させていただきます。
当社は、医薬品開発、あるいは品質管理に必要な各種標準物質の専門メーカーです。
1 | 2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18
(R)-(+)-Bupivacaine HCl |
CAS No.: |
27262-45-9 |
|
Formula: |
C18H28N2O . HCl |
Controlled Substance: |
False |
Details: |
Anesthetic (local) |
(R)-(+)-Metoprolol |
CAS No.: |
81024-43-3 37350-58-6 |
|
Formula: |
C15H25NO3 |
Controlled Substance: |
False |
Details: |
Antihypertensive; antianginal; antiarrhythmic (class II). |
(R)-(+)-Sibutramine HCl |
CAS No.: |
154752-45-1 106650-56-0 |
|
Formula: |
C17H26ClN . HCl |
Controlled Substance: |
False |
Details: |
Antiobesity agent. |
(R)-Oxybutynin HCl |
CAS No.: |
119618-21-2 5633-20-5 |
|
Formula: |
C22H31NO3 |
Controlled Substance: |
False |
Details: |
In treatment of urinary incontinence. |
(S)-(-)-Bupivacaine HCl |
CAS No.: |
27626-47-1 |
|
Formula: |
C18H28N2O . HCl |
Controlled Substance: |
False |
Details: |
Anesthetic (local) |
(S)-(-)-Metoprolol |
CAS No.: |
81024-42-2 37350-58-6 |
|
Formula: |
C15H25NO3 |
Controlled Substance: |
False |
Details: |
Antihypertensive; antianginal; antiarrhythmic (class II). |
(S)-(-)-Sibutramine HCl |
CAS No.: |
153341-23-2 106650-56-0 |
|
Formula: |
C17H26ClN . HCl |
Controlled Substance: |
False |
Details: |
Antiobesity agent. |
(S)-(+)-Cicletanine |
CAS No.: |
109784-90-9 |
|
Formula: |
C14H12ClNO2 |
Controlled Substance: |
False |
Details: |
Antihypertensive |
(S)-(+)-Citalopram Oxalate |
CAS No.: |
128196-01-0 59729-33-8 |
|
Formula: |
C20H21FN2O. C2H2O4 |
Controlled Substance: |
False |
Details: |
Antidepressant |
(S)-(+)-Doxazosin |
CAS No.: |
104874-86-4 |
|
Formula: |
|
Controlled Substance: |
False |
Details: |
Antihypertensive |
(S)-(+)-Zopiclone |
CAS No.: |
138729-47-2 43200-80-2 |
|
Formula: |
C17H17ClN6O3 |
Controlled Substance: |
False |
Details: |
Sedative, hypnotic. |
(S)-Oxybutynin HCl |
CAS No.: |
119618-22-3 5633-20-5 |
|
Formula: |
C22H31NO3 |
Controlled Substance: |
False |
Details: |
In treatment of urinary incontinence. |
1 | 2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18